| abstract |
The present invention provides, among other things, new benzylamine compounds of formula (I), compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism. In the compounds of formula (I), A is a substituted or an unsubstituted monocyclic or bicyclic, heterocyclic moiety, comprising from 5 to 10 ring atoms, inclusive, and comprising at least one heteroatom or heterogroup selected independently from >O, >N-, >S, >NR10, >SO2, or >CO. (see formula I) |